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ABSTRACT
AMOD is a web-based program that aids in the func-
tional evaluation of nucleotide sequences through
sequencecharacterizationandantisensemorpholino
oligonucleotide (target site) selection. Submitted
sequences are analyzed by translation initiation site
prediction algorithms and sequence-to-sequence
comparisons; results are used to characterize
sequence features required for morpholino design.
Within a defined subsequence, base composition
and homodimerization values are computed for all
putative morpholino oligonucleotides. Using these
properties, morpholino candidates are selected and
compared with genomic and transcriptome data-
baseswiththegoaltoidentifytarget-specificenriched
morpholinos. AMOD has been used at the University
of Minnesota to design  200 morpholinos for a func-
tional genomics screen in zebrafish. The AMOD
web server and a tutorial are freely available to both
academic and commercial users at http://www.
secretomes.umn.edu/AMOD/.
INTRODUCTION
Vertebrate genomes contain an estimated 20–30K genes
involved in diverse processes; many encoding proteins with
unknown function. The annotation of these genes remains
a major step in understanding the vertebrate genome. The
development of morpholino-based gene ‘knockdown’ techno-
logy provides a method for identifying function from primary
sequence, on a genome-wide scale in many vertebrates (1–7).
Sequence-driven screens for functional annotation of genomic
data are being developed in systems that lack the high cost,
signiﬁcant time and infrastructure commitments associated
with traditional model vertebrates. RNAi-based screening
in nematode (8) and ﬂy tissue culture cells (9) have applied
‘knockdown’ strategies to sequence-speciﬁc annotation, and
siRNA has been effectively applied in mammalian tissue
culture models (10). However, these approaches remain
impractical for large-scale in vivo work.
Phosphorodiamidatemorpholinooligonucleotides(morpho-
linos) are non-classical antisense reagents that modulate gene
expression by inhibiting protein translation or inducing altern-
ative splicing events. A synthetic DNA analog that contains a
six-member morpholino ring and a neutral charge phosphoro-
diamidate backbone, morpholinos are resistant to nuclease
digestion (8) and are freely water-soluble (9). Morpholinos
overcome many limitations associated with traditional anti-
sense reagents (11) and have been effectively used in many
eukaryotes (1–7,11,12). The effect morpholinos cause on the
expression is determined by the position targeted within a
nucleotide sequence. Morpholinos targeting the 50-untrans-
lated regions (50-UTRs) in proximity to the translational
initiation site (TIS) disrupt ribosomal complex formation
and inhibit protein translation of mRNA, while morpholinos
targeting pre-mRNA splice sites can induce alternative
splicing events (12–14). Consequently, effective morpholino
design requires a clear understanding of nucleotide sequence
characteristics in addition to the biochemical properties of
the morpholino oligonucleotides. Since signiﬁcant sequence
analyses are required for informed morpholino design, the
application of this technology to large-scale screens (5,15)
necessitates a software tool capable of efﬁcient and accurate
target sequence selection and morpholino design.
Programs for siRNA design include some, but not all, of the
necessary processes required for morpholino design (16–19).
Both siRNA and morpholino design require computation of
biochemical properties of short oligonucleotides, including
base composition and homogeneous nucleotide run calcula-
tions. However, siRNA does not require a detailed analysis of
oligonucleotide binding position relative to target nucleotide
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doi:10.1093/nar/gki453sequence features. Similar programs for morpholino-speciﬁc
design are not currently available, although the sole com-
mercial supplier of morpholinos, Gene Tools, offers a free,
proprietary design service (http://www.gene-tools.com/) that
requires prior knowledge of the translational start codon in
the mRNA and provides very limited sequence design and
analysis options to the user. AMOD implements morpholino
design guidelines similar to those recommended by Gene
Tools, such as avoidance of nucleotide motifs that form stable
localized secondary structures or decrease water solubility.
In addition, AMOD includes an integrated multiple-species
sequence comparison and host-speciﬁc genomic sequence val-
idation and uniqueness assessment capabilities. The resulting
output provides the user with a range of potential oligonuc-
leotide designs suitable for use in a variety of biological
applications, including the most common use as inhibitors
of mRNA translation or for the alteration of pre-mRNA spli-
cing. AMOD is a transparent, versatile and effective tool for
short oligonucleotide and primer design.
MATERIALS AND METHODS
AMOD is written in PERL (http://www.perl.org/) and uses
HTML and JavaScript for the user interface. BioPerl modules
(20) are used for BLAST parsing and nucleotide-to-protein
sequence translation. TIS predictions are made using the
ATGpr web server (21). Sequence-to-sequence comparisons
are performed using a local installation of NCBI BLAST ver-
sion 2.1.2. Sequence comparisons may be made against ver-
tebrate RefSeq proteins and the Ensembl zebraﬁsh genomic
sequence set, housed in the Vertebrate Secretome and CTT-
ome database (http://www.secretomes.umn.edu/).
RESULTS AND DISCUSSION
AMOD
The AMOD design process consists of six steps separated into
two phases, as shown in Figure 1. Phase one includes steps
to characterize the nucleotide sequence and aid users in iden-
tifying key sequence features, including the TIS and intron–
exon splice sites. To facilitate the design of morpholinos
for translational inhibition, TIS’s are predicted using ATGpr,
a linear discriminate analysis program (21). Nucleotide
sequences are automatically submitted to the ATGpr web ser-
ver and predicted TISs ranked by prediction reliability scores,
indices deﬁning the resulting open reading frame, and agree-
ment with Kozak’s consensus sequence (22) is obtained. This
program is used in AMOD because of its superior performance
when analyzing expressed sequence tag (EST) sequences (23).
To compliment this analysis, AMOD also performs an internal
scan for ATG start codons. The scan identiﬁes all occurrences
ofthe‘ATG’ codon,the correspondingreadingframe,assesses
agreement to Kozak’s consensus sequence and identiﬁes the
closest in-frame, upstream stop codon. Putative translational
start sites identiﬁed by either method can be selected, and
the TIS position highlighted in a display of the target gene
sequence (Figure 2B).
Homology modeling is used to further characterize the
nucleotide sequences and conﬁrm the location of the TIS.
Homology modeling is also useful for the identiﬁcation of
splice junctions for splice site morpholinos. Provided that
25 bases on either side of the splice junction can be identiﬁed,
other parameters for the design of splice site morpholinos
are either similar to TIS-targeted morpholinos or yet to be
determined. Users may execute sequence comparisons against
RefSeq protein sequences or against a user supplied reference
sequence set on the AMOD server. Users can also choose
to upload an output ﬁle from a previously executed BLAST
comparison, providedthe outputisintext format andthe target
nucleotide sequences were from the BLAST query sequences.
The 10 highest scoring alignments for a gene sequence
are presented in a BLAST report and alignment summary
(Figure 2A). For blastx comparisons, N-terminal alignment
extensions are dynamically constructed to aid users in assess-
ing the target gene’s 50 completeness, using methods described
previously (24).
Phase two of the AMOD process entails the selection of
a speciﬁc morpholino oligonucleotide, within the deﬁned
gene subsequence possessing biochemical properties to
improve morpholinowater solubilityand efﬁcacy as pioneered
by Gene Tools. These considerations are the same for mor-
pholinos targeting both TIS as well as splice junctions. AMOD
creates an exhaustive list of putative morpholino oligonuc-
leotides 25 bases long; the oligonucleotide length may be
modiﬁed but is set to the size considered to result in optimal
morpholino performance (25,26). For each morpholino, the
G%, C%, A%, GC%, maximum number of consecutive
adenines and maximum number of consecutive guanines in
the oligonucleotide are calculated. Morpholino intra-strand
Figure 1. Process flow chart for AMOD. The program consists of six steps,
encompassing two phases: target sequence characterization and morpholino
selection.
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occurring inall possible self-to-self, ungappedalignments. For
example, Figure 3 illustrates a morpholino self-to-self align-
ment with an intra-strand binding score of 30, 18 from six G–C
bonds and 12 from six A–T bonds. All intra-strand binding
alignments are reported, and the alignments yielding the
maximum global intra-strand binding and the maximum
intra-strand binding constrained to a four-base window are
noted (Figure 4A). The list of putative morpholino oligonuc-
leotides can be ﬁltered using base composition, or using the
intra-strand binding score to allow users to identify sequences
with the least intra-strand binding. Default thresholds for base
composition and intra-strand binding properties are set to
existing morpholino design guidelines; however, users may
modify these values to ﬁt custom design criteria.
A critical aspect of antisense reagent design is the evalu-
ation of the reagent’s target speciﬁcity (11,13). AMOD pro-
vides a second set of BLAST comparisons between select
morpholinos and genomic sequences or the transcriptome to
identify all sequences complementary to the selected mor-
pholino oligonucleotides (Figure 4B). These comparisons
enable a user to select a morpholino that maximizes binding
to the target gene with high speciﬁcity while minimizing bind-
ing to other gene targets that may induce effects unrelated to
the speciﬁc knockdown of the target gene.
User interaction
A design session on the AMOD web server begins with the
entry of a user-selected target nucleotide sequence in the
Figure 2. Target sequence evaluation phase. (A) The 10 highest scoring alignments for a gene sequence are presented in a BLAST report and alignment summary.
(B) Putative start sites identified by either method can be selected, and the TIS position highlighted in gray text in a display of the target gene sequence.
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a sequence ﬁle may be uploaded. AMOD then performs
TIS calculations on all entered sequences and asks users
whether BLAST comparisons are desired. Following the com-
putationor bypass ofBLAST comparisons,usersare prompted
to select a single input sequence against which morpholino
design will proceed. Once a user has deﬁned a subsequence,
reviewed the putative morpholinos, and identiﬁed an accept-
able oligonucleotide, the morpholino sequence characteristics
are written to an output ﬁle.Theuser may then analyze another
sequence from the input sequence set or exit the program.
AMOD application
AMOD was used to design morpholinos for the University
of Minnesota’s functional genomics screen in zebraﬁsh. This
screen utilizes comparative genomic data mining strategies
to identify conservation of higher-order biological processes
amongvertebrates.Useofmorpholinosallowshigh-throughput
rates of genetic analysis without the inherent redundancy of
forward-genetic approaches that typically result in multiple
mutations within the same gene. The screen has analyzed
255 gene sequences to date, using 189 morpholinos targeting
157 unique genes were designed. During AMOD’s use, the
program’s functionality and user interface were evaluated and
improved.
The positive results of the ongoing functional genomics
morpholino screen validate the use of morpholinos for this
approach (27) and demonstrate the capacity of AMOD to
Figure 3. Illustrates intra-strand binding approximation from a morpholino
self-to-selfalignment.Inthisfigure,thetotalbindingscoreis30:18fromsixG–
C bonds and 12 from six A–T bonds.
Figure 4. Oligonucleotide selection phase. (A) All intra-strand binding alignments are reported, and the alignments yielding the maximum global intra-strand
binding and the maximum intra-strand binding constrained to a four-base window are noted. (B) AMOD uses a second set of BLAST comparisons between select
morpholinos and genomic sequences or the transcriptome to identify genes that could be targeted by the selected morpholino oligonucleotides.
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spite of this success, the analysis of relationships between
phenotypic outcomes and sequence characteristics of mor-
pholinos used in this screen have only identiﬁed a modest
correlation between morpholino effectiveness and a minimum
base composition threshold that was subsequently integrated
into AMOD. No other improvement in parameters for mor-
pholino design based on target gene sequence was strongly
suggested by these outcomes. In addition, multiple factors
arising from the use of a continually evolving zebraﬁsh
genomic sequence database and incomplete EST sequence
data limit the ability to discern speciﬁc guidelines for
morpholino design or to evaluate the capacity of AMOD to
improvemorpholinodesignfromthisinitialfunctionalgenom-
ics screen. The exhaustive, robust evaluation of morpholino
design parameters and programs for morpholino design await
the identiﬁcation of a controlled reference set, including both
efﬁcacious and non-efﬁcacious morpholinos. Until then,
AMOD addressesthe need to streamline target sequence selec-
tion and morpholino design, e.g. in support of high-throughput
approaches for morpholino screening.
Comparison with other morpholino design services
The sole commercial supplier of morpholinos, Gene Tools,
offers a free, proprietary design service (http://www.
gene-tools.com/). To our knowledge, this is presently the
onlyothermorpholinodesignservice,requiresprioruserknow-
ledge of the translational start codon in the selected target
mRNA,andprovidesverylimitedsequencedesignandanalysis
options. Based on the success of this proprietary method for
morpholino design, AMOD was developed to implement sim-
ilar morpholino design guidelines, such as avoidance of nuc-
leotidemotifsthatformstablelocalizedsecondarystructuresor
decreasewatersolubility.Inanefforttoimproveontheseinitial
design parameters and to incorporate the advancing genomic
and transcriptome databases into morpholino design, AMOD
includes an integrated multiple-species sequence comparison
and host-speciﬁc genomic sequence validation and uniqueness
assessment capabilities. The resulting output provides the user
with a range of potential oligonucleotide designs suitable for
use in a variety of biological applications, including their most
commonuseasinhibitorsofmRNAtranslationorforthealtera-
tionofpre-mRNAsplicing.AMODthusprovidestheuserwith
a transparent design tool offering an increased number of oli-
gonucleotide design options while implementing genomics-
wide sequence criteria not found in the other available mor-
pholino design option.
AVAILABILITY
AMOD web server is freely accessible to academic and com-
mercial users at http://www.secretomes.umn.edu/AMOD/.
A graphical step-by-step tutorial is available. For questions,
comments andsuggestions pertainingtoAMOD,thereisa link
to an online ‘Contact Us’ form on every web page.
FUTURE DEVELOPMENTS AND CONCLUSIONS
The AMOD web server is a tool designed for selecting oligo-
nucleotides for the construction of antisense morpholinos
against target nucleotide sequences. Planned additions to
the server include intron–exon and exon–intron splice site
predictions, entropy calculations and a ranking system for
putative morpholino designs.
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